We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

AI-Powered Algorithm Offers Quick, Contactless Blood Pressure and Diabetes Screening

By HospiMedica International staff writers
Posted on 13 Nov 2024
Image: The AI-powered algorithm offers quick, no-contact screenings for high blood pressure and diabetes (Photo courtesy of 123RF)
Image: The AI-powered algorithm offers quick, no-contact screenings for high blood pressure and diabetes (Photo courtesy of 123RF)

A newly developed system that combines high-speed video with an artificial intelligence (AI)-powered algorithm may provide a quick, non-contact method for screening high blood pressure and Type 1 or Type 2 diabetes, eliminating the need for blood tests, blood pressure cuffs, or costly wearable devices. Although the system is still in the early stages of development, it could eventually offer rapid, contactless screenings for high blood pressure and diabetes, potentially aiding in the monitoring of treatment responses.

In the study, researchers at the University of Tokyo (Tokyo, Japan) evaluated the effectiveness of a high-speed video camera capable of capturing face and palm recordings at 150 images per second. By using wavelength data to detect pulse waves, the research team applied an AI algorithm to identify high blood pressure and diabetes through blood flow characteristics in the skin as captured by the video. When compared to continuous blood pressure monitor readings taken simultaneously with the video recordings, the video/algorithm combination demonstrated 94% accuracy in detecting stage 1 hypertension, as defined by the American Heart Association’s guidelines for blood pressure of 130/80 mm Hg or higher.

In comparison with continuous blood pressure monitor readings, the 30-second video/algorithm method showed 86% accuracy in detecting elevated blood pressure, while the 5-second video/algorithm method had 81% accuracy. Normal blood pressure readings were defined according to the Japanese Society of Hypertension guidelines (2018), which specify systolic pressure below 115 mm Hg and diastolic pressure below 75 mm Hg. When compared to hemoglobin A1c blood test results for diabetes screening, the video/algorithm system was 75% accurate in identifying individuals with diabetes. The A1c test measures average blood sugar levels over the previous 1-2 months. Although the technology shows promise, additional steps are needed before the video/algorithm combination can be applied outside of a research setting.

“To detect high blood pressure, we need to incorporate an algorithm that considers arrhythmias or irregular heartbeats,” said study author Ryoko Uchida, B.Sc. (Pharm.), a project researcher in the department of advanced cardiology at the University of Tokyo. “In the future, the prototype camera we used to develop the algorithm could be substituted with an affordable sensor that uses only the essential wavelengths and requires just a few seconds to gather data. Once it reaches that stage, it may be added to smartphones (or even hung on a mirror where someone sits for a few moments), may be mass-produced and inexpensive.”

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
MR Trolley
MR9002
New
Knee Arthroscopy Holder
Reison 10-353 XL

Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more